Validation of HPLC-MS/MS methods for analysis of loxapine, amoxapine, 7-OH-loxapine, 8-OH-loxapine and loxapine N-oxide in human plasma.
Jennifer S D Zimmer, Shane R Needham, Chad D Christianson, Crystal M Piekarski, Chrystal N Sheaff, Keith Huie, Andrea R Reed, Lori Takahashi
Index: Bioanalysis 2(12) , 1989-2000, (2010)
Full Text: HTML
Abstract
Two ESI-LC-MS/MS methods were validated for the quantitative analysis of loxapine, amoxapine, 7-OH-loxapine, 8-OH-loxapine and loxapine N-oxide in human K(2)EDTA plasma. Cation-exchange solid-phase extraction (SPE) was used to extract loxapine, amoxapine and the two hydroxylated metabolites, and organic precipitation was used to quantify loxapine N-oxide.Both methods were shown to be accurate (±13%), intra-assay precision was less than 15%, and inter-assay precision was less than 10% in all instances across the entire dynamic range of the assays (0.0500-50.0 ng/ml for the SPE method and 0.100-25.0 ng/ml for the precipitation method).The validated methods for loxapine, amoxapine, 7-OH-loxapine, 8-OH-loxapine and loxapine N-oxide have been used to successfully support clinical trials.
Related Compounds
Related Articles:
2012-01-01
[J. Pharm. Biomed. Anal. 58 , 83-93, (2012)]
In vitro aerosol characterization of Staccato(®) Loxapine.
2011-01-17
[Int. J. Pharm. 403(1-2) , 101-8, (2011)]
2012-03-01
[Int. J. Clin. Pract. 66(3) , 318-25, (2012)]
The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009.
2011-10-01
[Can. J. Psychiatry. 56(10) , 630-4, (2011)]
2011-02-01
[J. Comput. Aided Mol. Des. 25(2) , 163-9, (2011)]